Regulation of proliferation of skeletal muscle precursor cells by NADPH oxidase

Antioxidants and Redox Signaling

Volumn 10, Issue 3, 2008, Pages 559-574

  Mofarrahi, Mahroo ^a   Brandes, Ralf P ^b   Gorlach, Agnes ^c   Hanze, Joerg ^d   Terada, Lance S ^e   Quinn, Mark T ^f   Mayaki, Dominique ^a   Petrof, Basil ^a   Hussain, Sabah N A ^a,g  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b GOETHE UNIVERSITY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f MONTANA STATE UNIVERSITY   (United States)

^g ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; APOCYNIN; PROTEIN P22; PROTEIN P47; PROTEIN P67; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; MALE; MOUSE; MUSCLE CELL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DNA PRIMERS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; MUSCLE, SKELETAL; NADPH OXIDASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

MURINAE;

EID: 38349078194     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1792     Document Type: Article

References (43)

1. Ago T, Kitazono T, Ooboshi H, Iyama T, Han YH, Takada J, Wakisaka M, Ibayashi S, Utsumi H, and Iida M. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109: 227-233, 2004.
2. Babior BM, Lambeth JD, and Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 397: 342-344, 2002.
3. Banfi B, Clark RA, Steger K, and Krause KH. Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J Biol Chem 278: 3510-3513, 2003.
4. Bedard K and Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313, 2007.
5. Buck M and Chojkier M. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J 15: 1753-1765, 1996.
6. Burch PM and Heintz NH. Redox regulation of cell-cycle re-entry: cyclin D1 as a primary target for the mitogenic effects of reactive oxygen and nitrogen species. Antioxid Redox Signal 7: 741-751, 2005.
7. Burch PM, Yuan Z, Loonen A, and Heintz NH. An extracellular signal-regulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry. Mol Cell Biol 24: 4696-4709, 2004.
8. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 18: 775-794, 1995.
9. Cai H, Griendling KK, and Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 24: 471-478, 2003.
10. phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269: 131-140, 2001.
11. Deveci D, Marshall JM, and Egginton S. Relationship between capillary angiogenesis, fiber type, and fiber size in chronic systemic hypoxia. Am J Physiol Heart Circ Physiol 281: H241-H252, 2001.
12. 2+ stimulates ERK, CREB, early genes. J Cell Physiol 209: 379-388, 2006.
13. Goyal P, Weissmann N, Rose F, Grimminger F, Schafers HJ, Seeger W, and Hanze J. Identification of novel Nox4 splice variants with impact on ROS levels in A549 cells 2. Biochem Biophys Res Commun 329: 32-39, 2005.
14. phox participates in activation of RelA in endothelial cells. J Biol Chem 278: 17210-17217, 2003.
15. Gu Y, Xu YC, Wu RF, Souza RF, Nwariaku FE, and Terada LS. TNFα activates c-Jun amino terminal kinase through p47(phox). Exp Cell Res 272: 62-74, 2002.
16. Gupta K, Kshirsagar S, Li W, Ramakrishnam S, Gui L, Gupta P, Law PY, and Hebbel RP. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp Cell Res 247: 495-504, 1999.
17. 2: role in cell survival following oxidant injury. J Biol Chem 271: 4138-4142, 1996.
18. Harfouche R, Gratton JP, Yancopoulos GD, and Hussain SNA. Angiopoietin-1 activates both anti- and pro-apoptotic mitogen activated protein kinases. FASEB J 17: 1523-1525, 2003.
19. Hawke TJ and Garry DJ. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 91: 534-551, 2001.
20. Hidalgo C, Sanchez G, Barrientos G, and Racena-Parks P. A transverse tubule NADPH oxidase activity stimulates calcium release from isolated triads via ryanodine receptor type 1 S -glutathionylation. J Biol Chem 281: 26473-26482, 2006.
21. Hutchinson DS, Csikasz RI, Yamamoto DL, Shabalina IG, Wikström P, Wilcke M, and Bengtsson T. Diphenylene iodonium stimulates glucose uptake in skeletal muscle cells through mitochondrial complex I inhibition and activation of AMP-activated protein kinase. Cell Signal 19: 1610-1620, 2007.
22. Javeshghani D, Magder S, Barreiro E, Quinn MT, and Hussain SNA. Molecular characterization of a superoxide-generating NAD(P)H oxidase in the ventilatory muscles. Am J Resp Crit Care Med 165: 412-418, 2002.
23. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189, 2004.
24. Langen RC, Schols AM, Kelders MC, van d, V, Wouters EF, and Janssen-Heininger YM. Tumor necrosis factor-α inhibits myogenesis through redox-dependent and -independent pathways. Am J Physiol Cell Physiol 283: C714-C721, 2002.
25. Li SP, Junttila MR, Han J, Kahari VM, and Westermarck J. p38 Mitogen-activated protein kinase pathway suppresses cell survival by inducing dephosphorylation of mitogen-activated protein/extracellular signal-regulated kinase kinase1,2. Cancer Res 63: 3473-3477, 2003.
26. Li Y, Zhu H, Kuppusamy P, Roubaud V, Zweier JL, and Trush MA. Validation of lucigenin (bis-N-methylacridinium) as a chemiluminescence probe for detecting superoxide anions radical production by enzymatic and cellular systems. J Biol Chem 273: 2015-2023, 1998.
27. Liochev SI and Fridovich I. Lucigenin (bis-N-methylacridinium) as a mediator of superoxide anion production. Arch Biochem Biophys 337: 115-120, 1997.
28. Lochmuller H, Johns T, and Shoubridge EA. Expression of the E6 and E7 genes of human papillomavirus (HPV16) extends the life span of human myoblasts. Exp Cell Res 248: 186-193, 1999.
29. Mahadev K, Zilbering A, Zhu L, and Goldstein BJ. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem 276: 21938-21942, 2001.
30. Manning BD, Logsdon MN, Lipovsky AI, Abbott D, Kwiatkowski DJ, and Cantley LC. Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev 19: 1773-1778, 2005.
31. Meng TC, Fukada T, and Tonks NK. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9: 387-399, 2002.
32. Petry A, Djordjevic T, Weitnauer M, Kietzmann T, Hess J, and Gorlach A. NOX2 and NOX4 mediate proliferative response in endothelial cells. Antioxid Redox Signal 8: 1473-1484, 2006.
33. Rosenblatt JD, Lunt AI, Parry DJ, and Partridge TA. Culturing satellite cells from living single muscle fiber explants. In Vitro Cell Dev Biol Anim 31: 773-779, 1995.
34. Sanlioglu S, Williams CM, Samavati L, Butler NS, Wang G, McCray PB Jr, Ritchie TC, Hunninghake GW, Zandi E, and Engelhardt JF. Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factoralpha secretion through IKK regulation of NF-κB. J Biol Chem 276: 30188-30198, 2001.
35. Schreck R, Rieber P, and Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 10: 2247-2258, 1991.
36. Sekulic A, Hudson CC, Homme JL, Yin P, Otterness DM, Karnitz LM, and Abraham RT. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res 60: 3504-3513, 2000.
37. Shaulian E and Karin M. AP-1 in cell proliferation and survival. Oncogene 20: 2390-2400, 2001.
38. 2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
39. Toniolo L, Maccatrozzo L, Patruno M, Caliaro F, Mascarello F, and Reggiani C. Expression of eight distinct MHC isoforms in bovine striated muscles: evidence for MHC-2B presence only in extraocular muscles. J Exp Biol 208: 4243-4253, 2005.
40. Wang Z, Yang H, Tachado SD, Capo-Aponte JE, Bildin VN, Koziel H, and Reinach PS. Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells. Invest Ophthalmol Vis Sci 47: 5267-5275, 2006.
41. Wei Y, Sowers JR, Nistala R, Gong H, Uptergrove GM, Clark SE, Morris EM, Szary N, Manrique C, and Stump CS. Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells. J Biol Chem 281: 35137-35146, 2006.
42. phox to membrane ruffles through WAVE1. J Biol Chem 278: 36830-36840, 2003.
43. Wullschleger S, Loewith R, and Hall MN. TOR signaling in growth and metabolism. Cell 124: 471-484, 2006.